PharmaBoardroom

China Pharma News Roundup May 11th 2020

Top recent news from Chinese pharma, including listings on the Hong Kong Stock Exchange, Junshi's out-licensing of a potential COVID-19 treatment to…

Carol Lynch – President, Sandoz US; Head, Sandoz North…

Carol Lynch of Sandoz US talks candidly on the US generics market from an international perspective, market access, biosimilars uptake, talent…

Standing on the Shoulders of Giants: The Art & Science of…

DataArt's Daniel Piekarz looks at how machine learning and artificial intelligence can play into the important task of drug repurposing, potentially…

Latin America Pharma News Roundup May 2020

Below we highlight recent news in the Latin America region, focusing on Argentina, Colombia and Chile. Top stories cover the fight against COVID-19,…

The UAE: A Gathering Force

Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat overlooked by many drug makers, most…

Driss Chaoui – CEO, Afric-Phar, Morocco

Dr Driss Chaoui, CEO of Afric-Phar, one of the leading domestic companies in Moroccan pharma, provides insight into the major developments that have…

Worried About Biogen’s Aducanumab? Don’t Be

Dr Neil Cashman examines the recent news around Biogen's Alzheimer's treatment aducanumab, assuages some investor fears, and underlines the…

Hot Topics in US Healthcare & Pharma

So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…